Solved

Passage The HIV-Derived Transactivator of Transcription (Tat) Is a Short Peptide

Question 301

Multiple Choice

Passage
The HIV-derived transactivator of transcription (Tat) is a short peptide with the sequence RKKRRQRRRPPQ.  When paired with liposomes (ie, synthetic vesicles) composed of cationic lipids, Tat can transport large molecules across cell membranes and has been studied as a vector for gene therapy.  However, Tat delivers cargo to cells with relatively low efficiency.  Researchers hypothesized that a Tat homodimer could yield stronger DNA binding than the monomer, which may improve the efficiency of DNA delivery.To study this hypothesis, Tat and two variant peptides (Variants 1 and 2) were produced by solid-phase peptide synthesis, in which the growing peptide chain is immobilized on polystyrene beads.  Unlike biological systems, solid-phase synthesis assembles peptides from the C-terminus to the N-terminus, as shown in Figure 1.
Passage The HIV-derived transactivator of transcription (Tat)  is a short peptide with the sequence RKKRRQRRRPPQ.  When paired with liposomes (ie, synthetic vesicles)  composed of cationic lipids, Tat can transport large molecules across cell membranes and has been studied as a vector for gene therapy.  However, Tat delivers cargo to cells with relatively low efficiency.  Researchers hypothesized that a Tat homodimer could yield stronger DNA binding than the monomer, which may improve the efficiency of DNA delivery.To study this hypothesis, Tat and two variant peptides (Variants 1 and 2)  were produced by solid-phase peptide synthesis, in which the growing peptide chain is immobilized on polystyrene beads.  Unlike biological systems, solid-phase synthesis assembles peptides from the C-terminus to the N-terminus, as shown in Figure 1.    <strong>Figure 1</strong>  Simplified schematic of one round of solid-phase peptide synthesis.  The protecting group is removed during deprotection.  The process is repeated until the peptide is complete.Variants 1 and 2 contained a C-terminal and an N-terminal cysteine residue, respectively.  Each variant was allowed to dimerize by disulfide bond formation.  Peptide-DNA binding interactions were then studied by mixing varying amounts of each peptide with plasmid DNA encoding luciferase protein (pLuc) .  The resulting peptide-DNA complexes were run on agarose gels, with results displayed in Figure 2.    <strong>Figure 2</strong>  Agarose gel results for pLuc plasmid exposed to varying amounts of each peptideEqual concentrations of each type of peptide-DNA complex were then incubated with cationic liposomes and exposed to cultured cells for 24 hours.  The cells were then assessed for luciferase activity.  Greater luciferase activity indicated more efficient delivery of the pLuc plasmid.  The results are shown in Figure 3.    <strong>Figure 3</strong>  Plasmid delivery efficiency of three peptides, as measured by induced luciferase activity Adapted from Lee S-J, Yoon S-H, Doh K-O. Enhancement of gene delivery using novel homodimeric tat peptide formed by disulfide bond. J Microbiol Biotechnol. 2011;21(8) :802-807. -Do the data in Figure 2 and Figure 3 support the hypothesis that stronger peptide-DNA interactions yield more efficient plasmid delivery? A) Yes; the order of binding strength shown in Figure 2 is the same as the order of delivery efficiency shown in Figure 3. B) No; the Variant 2 dimer shows the weakest DNA binding but is more efficient than the Tat monomer at cargo delivery. C) No; the Tat monomer shows the strongest DNA binding but the least efficient plasmid delivery. D) No; the Variant 2 dimer binds DNA with greater strength than the Variant 1 dimer, but Variant 1 has the most efficient plasmid delivery. Figure 1  Simplified schematic of one round of solid-phase peptide synthesis.  The protecting group is removed during deprotection.  The process is repeated until the peptide is complete.Variants 1 and 2 contained a C-terminal and an N-terminal cysteine residue, respectively.  Each variant was allowed to dimerize by disulfide bond formation.  Peptide-DNA binding interactions were then studied by mixing varying amounts of each peptide with plasmid DNA encoding luciferase protein (pLuc) .  The resulting peptide-DNA complexes were run on agarose gels, with results displayed in Figure 2.
Passage The HIV-derived transactivator of transcription (Tat)  is a short peptide with the sequence RKKRRQRRRPPQ.  When paired with liposomes (ie, synthetic vesicles)  composed of cationic lipids, Tat can transport large molecules across cell membranes and has been studied as a vector for gene therapy.  However, Tat delivers cargo to cells with relatively low efficiency.  Researchers hypothesized that a Tat homodimer could yield stronger DNA binding than the monomer, which may improve the efficiency of DNA delivery.To study this hypothesis, Tat and two variant peptides (Variants 1 and 2)  were produced by solid-phase peptide synthesis, in which the growing peptide chain is immobilized on polystyrene beads.  Unlike biological systems, solid-phase synthesis assembles peptides from the C-terminus to the N-terminus, as shown in Figure 1.    <strong>Figure 1</strong>  Simplified schematic of one round of solid-phase peptide synthesis.  The protecting group is removed during deprotection.  The process is repeated until the peptide is complete.Variants 1 and 2 contained a C-terminal and an N-terminal cysteine residue, respectively.  Each variant was allowed to dimerize by disulfide bond formation.  Peptide-DNA binding interactions were then studied by mixing varying amounts of each peptide with plasmid DNA encoding luciferase protein (pLuc) .  The resulting peptide-DNA complexes were run on agarose gels, with results displayed in Figure 2.    <strong>Figure 2</strong>  Agarose gel results for pLuc plasmid exposed to varying amounts of each peptideEqual concentrations of each type of peptide-DNA complex were then incubated with cationic liposomes and exposed to cultured cells for 24 hours.  The cells were then assessed for luciferase activity.  Greater luciferase activity indicated more efficient delivery of the pLuc plasmid.  The results are shown in Figure 3.    <strong>Figure 3</strong>  Plasmid delivery efficiency of three peptides, as measured by induced luciferase activity Adapted from Lee S-J, Yoon S-H, Doh K-O. Enhancement of gene delivery using novel homodimeric tat peptide formed by disulfide bond. J Microbiol Biotechnol. 2011;21(8) :802-807. -Do the data in Figure 2 and Figure 3 support the hypothesis that stronger peptide-DNA interactions yield more efficient plasmid delivery? A) Yes; the order of binding strength shown in Figure 2 is the same as the order of delivery efficiency shown in Figure 3. B) No; the Variant 2 dimer shows the weakest DNA binding but is more efficient than the Tat monomer at cargo delivery. C) No; the Tat monomer shows the strongest DNA binding but the least efficient plasmid delivery. D) No; the Variant 2 dimer binds DNA with greater strength than the Variant 1 dimer, but Variant 1 has the most efficient plasmid delivery. Figure 2  Agarose gel results for pLuc plasmid exposed to varying amounts of each peptideEqual concentrations of each type of peptide-DNA complex were then incubated with cationic liposomes and exposed to cultured cells for 24 hours.  The cells were then assessed for luciferase activity.  Greater luciferase activity indicated more efficient delivery of the pLuc plasmid.  The results are shown in Figure 3.
Passage The HIV-derived transactivator of transcription (Tat)  is a short peptide with the sequence RKKRRQRRRPPQ.  When paired with liposomes (ie, synthetic vesicles)  composed of cationic lipids, Tat can transport large molecules across cell membranes and has been studied as a vector for gene therapy.  However, Tat delivers cargo to cells with relatively low efficiency.  Researchers hypothesized that a Tat homodimer could yield stronger DNA binding than the monomer, which may improve the efficiency of DNA delivery.To study this hypothesis, Tat and two variant peptides (Variants 1 and 2)  were produced by solid-phase peptide synthesis, in which the growing peptide chain is immobilized on polystyrene beads.  Unlike biological systems, solid-phase synthesis assembles peptides from the C-terminus to the N-terminus, as shown in Figure 1.    <strong>Figure 1</strong>  Simplified schematic of one round of solid-phase peptide synthesis.  The protecting group is removed during deprotection.  The process is repeated until the peptide is complete.Variants 1 and 2 contained a C-terminal and an N-terminal cysteine residue, respectively.  Each variant was allowed to dimerize by disulfide bond formation.  Peptide-DNA binding interactions were then studied by mixing varying amounts of each peptide with plasmid DNA encoding luciferase protein (pLuc) .  The resulting peptide-DNA complexes were run on agarose gels, with results displayed in Figure 2.    <strong>Figure 2</strong>  Agarose gel results for pLuc plasmid exposed to varying amounts of each peptideEqual concentrations of each type of peptide-DNA complex were then incubated with cationic liposomes and exposed to cultured cells for 24 hours.  The cells were then assessed for luciferase activity.  Greater luciferase activity indicated more efficient delivery of the pLuc plasmid.  The results are shown in Figure 3.    <strong>Figure 3</strong>  Plasmid delivery efficiency of three peptides, as measured by induced luciferase activity Adapted from Lee S-J, Yoon S-H, Doh K-O. Enhancement of gene delivery using novel homodimeric tat peptide formed by disulfide bond. J Microbiol Biotechnol. 2011;21(8) :802-807. -Do the data in Figure 2 and Figure 3 support the hypothesis that stronger peptide-DNA interactions yield more efficient plasmid delivery? A) Yes; the order of binding strength shown in Figure 2 is the same as the order of delivery efficiency shown in Figure 3. B) No; the Variant 2 dimer shows the weakest DNA binding but is more efficient than the Tat monomer at cargo delivery. C) No; the Tat monomer shows the strongest DNA binding but the least efficient plasmid delivery. D) No; the Variant 2 dimer binds DNA with greater strength than the Variant 1 dimer, but Variant 1 has the most efficient plasmid delivery. Figure 3  Plasmid delivery efficiency of three peptides, as measured by induced luciferase activity
Adapted from Lee S-J, Yoon S-H, Doh K-O. Enhancement of gene delivery using novel homodimeric tat peptide formed by disulfide bond. J Microbiol Biotechnol. 2011;21(8) :802-807.
-Do the data in Figure 2 and Figure 3 support the hypothesis that stronger peptide-DNA interactions yield more efficient plasmid delivery?


A) Yes; the order of binding strength shown in Figure 2 is the same as the order of delivery efficiency shown in Figure 3.
B) No; the Variant 2 dimer shows the weakest DNA binding but is more efficient than the Tat monomer at cargo delivery.
C) No; the Tat monomer shows the strongest DNA binding but the least efficient plasmid delivery.
D) No; the Variant 2 dimer binds DNA with greater strength than the Variant 1 dimer, but Variant 1 has the most efficient plasmid delivery.

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions

Unlock this Answer For Free Now!

View this answer and more for free by performing one of the following actions

qr-code

Scan the QR code to install the App and get 2 free unlocks

upload documents

Unlock quizzes for free by uploading documents